Keyphrases
Bone Metastasis
100%
Antagonism
100%
Osteoclast Activation
100%
Inhibitor of Apoptosis Proteins
100%
NF-B
50%
Tumor Growth
40%
Osteoclast
30%
Osteoporosis
30%
Osteolysis
20%
Antiresorptive
20%
Anticancer Agents
20%
Tumor
10%
Clinical Trials
10%
Apoptosis
10%
Metastasis
10%
Cancer Types
10%
Cancer Treatment
10%
Positive Feedback Loop
10%
Tumor Metastasis
10%
Zoledronic Acid
10%
Osteoclastogenesis
10%
Tumor-associated
10%
Drug-resistant Tumor
10%
Osteoclast Inhibition
10%
Inhibiting Effect
10%
Co-treatment
10%
Bone Microenvironment
10%
Drug Sensitivity
10%
Skeletal Metastases
10%
Antagonist Treatment
10%
Medicine and Dentistry
Programmed Cell Death
100%
Bone Metastasis
100%
Osteoclast Activity
100%
Inhibitor of Apoptosis Protein
100%
Osteoclast
44%
Tumor Progression
44%
Phosphotransferase
33%
Osteoporosis
33%
Neoplasm
22%
Metastatic Carcinoma
22%
Osteolysis
22%
Anticancer Drug
22%
Cancer Therapy
11%
Malignant Neoplasm
11%
Clinical Trial
11%
Cancer
11%
Osteoclastogenesis
11%
Zoledronic Acid
11%
Positive Feedback
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
Bone Metastasis
100%
Inhibitor of Apoptosis Protein
100%
Phosphotransferase
75%
Neoplasm
50%
Malignant Neoplasm
50%
Anticancer Drug
50%
Clinical Trial
25%
Zoledronic Acid
25%
Metastasis
25%